UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 8-K
(Amendment No. 1)
CURRENT REPORT
Pursuant To Section 13 or 14(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) November 3, 2003
----------------
PSYCHEMEDICS CORPORATION
------------------------------------------------------
(Exact Name of Registrant As Specified In Its Charter)
DELAWARE
----------------------------------------------
(State if Other Jurisdiction of Incorporation)
1-13738 58-1701987
- ------------------------ ------------------------------------
(Commission File Number) (I.R.S. Employer Identification No.)
1280 Massachusetts Ave., Suite 200, Cambridge, MA 02138
- ------------------------------------------------- ----------
(Address of Principal Executive Offices) (Zip Code)
(617-868-7455)
----------------------------------------------------
(Registrant's Telephone Number, Including Area Code)
N/A
-------------------------------------------------------------
(Former name or former address, if changed since last report)
Explanatory Note
This amendment to the 8-K is filed in its entirety solely to correct
typographically errors under Item 12 changing the date of the Company's press
release to November 3, 2003 and the Company's quarter end to
September 30, 2003.
ITEM 7. FINANCIAL STATEMENTS, PRO-FORMA FINANCIAL INFORMATION AND EXHIBITS.
(c) Exhibits
The following exhibits are filed herewith:
99.1 Press Release dated November 3, 2003.
ITEM 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION.
On November 3, 2003, Psychemedics Corporation issued a press release
announcing preliminary results for the quarter ended September 30, 2003. The
press release is attached hereto as Exhibit 99.1 and incorporated by reference
herein.
The information in this Form 8-K and the Exhibit attached hereto shall not
be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of
1934 (the "Exchange Act") or otherwise subject to the liabilities of that
section, nor shall it be deemed incorporated by reference in any filing under
the Securities Act of 1933 or the Exchange Act, regardless of any general
incorporation language in such filing.
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this Report to be signed on its behalf by the
undersigned hereunto duly authorized.
PSYCHEMEDICS CORPORATION
Dated: November 4, 2003
By: /s/ Peter C. Monson
-----------------------------------------
Peter C. Monson, Chief Financial Officer
3